Cytokinetics Inc vs Grab Holdings Ltd. — how do they compare? Cytokinetics Inc trades at $81.99 (market cap $11.12B), while Grab Holdings Ltd. trades at $3.79 (market cap $15.54B). The key difference: Grab Holdings Ltd. is the larger of the two by market cap, and Cytokinetics Inc is trading nearer its 52-week high, Grab Holdings Ltd. nearer its low. Which is the better fit depends on your goals.
| CYTK | GRAB | |
|---|---|---|
Market Cap | $11.12B | $15.54B |
Sector | Technology | Technology |
52-Week High | $87.26 | $6.45 |
52-Week Low | $33.23 | $3.27 |
Enterprise Value | $11.59B | $11.23B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GRAB trades at $3.94, up 0.25% on the day, with a bullish technical signal and strong analyst support. The company achieved profitability in 2025 with $268M net income and 7.95% margin, showing significant improvement from prior losses. Revenue growth continues, reaching $3.37B in 2025. Recent news highlights market outperformance and investor attention, though the stock reacted negatively to Uber CEO's board departure in early July 2026.
Outlook remains positive with 91.67% analyst buy ratings and $5.45 consensus target, implying 38% upside. Key risks include competitive pressures in ride-hailing, execution challenges in expanding financial services, and potential market volatility. Profitability trajectory and cash flow sustainability are critical for maintaining investor confidence.
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →